Toho Holdings Co., Ltd. (8129.T)
JPY 4236.0
(0.09%)
JPY 4236.0
(0.09%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 19.33 Billion JPY | 49.72% |
| 2022 | 12.81 Billion JPY | 2.28% |
| 2021 | 12.52 Billion JPY | 191.12% |
| 2020 | 4.3 Billion JPY | -75.54% |
| 2019 | 17.59 Billion JPY | 11.45% |
| 2018 | 15.78 Billion JPY | -17.0% |
| 2017 | 19.01 Billion JPY | 33.5% |
| 2016 | 14.24 Billion JPY | -50.23% |
| 2015 | 28.61 Billion JPY | 185.69% |
| 2014 | 10.01 Billion JPY | -18.75% |
| 2013 | 12.32 Billion JPY | -22.35% |
| 2012 | 15.87 Billion JPY | 12.82% |
| 2011 | 14.07 Billion JPY | 141.02% |
| 2010 | 5.83 Billion JPY | -46.62% |
| 2009 | 10.93 Billion JPY | 262.1% |
| 2008 | 3.02 Billion JPY | -70.58% |
| 2007 | 10.26 Billion JPY | 10.01% |
| 2006 | 9.33 Billion JPY | 54.07% |
| 2005 | 6.05 Billion JPY | 78.31% |
| 2004 | 3.39 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.27 Billion JPY | -70.6% |
| 2023 Q2 | 4.63 Billion JPY | 150.35% |
| 2023 FY | 19.18 Billion JPY | 49.72% |
| 2023 Q1 | 1.85 Billion JPY | -56.51% |
| 2023 Q4 | 7.74 Billion JPY | 52.3% |
| 2023 Q3 | 5.08 Billion JPY | 9.68% |
| 2022 Q3 | 4.46 Billion JPY | 66.28% |
| 2022 Q2 | 2.68 Billion JPY | 92.34% |
| 2022 Q1 | 1.39 Billion JPY | -79.98% |
| 2022 FY | 12.81 Billion JPY | 2.28% |
| 2022 Q4 | 4.26 Billion JPY | -4.63% |
| 2021 Q2 | 1.22 Billion JPY | 93.39% |
| 2021 FY | 12.52 Billion JPY | 191.12% |
| 2021 Q1 | 635 Million JPY | -36.82% |
| 2021 Q3 | 3.68 Billion JPY | 200.16% |
| 2021 Q4 | 6.97 Billion JPY | 89.31% |
| 2020 Q1 | 1.77 Billion JPY | -59.4% |
| 2020 Q2 | -493 Million JPY | -127.82% |
| 2020 Q3 | 2.01 Billion JPY | 509.53% |
| 2020 Q4 | 1 Billion JPY | -50.22% |
| 2020 FY | 4.3 Billion JPY | -75.54% |
| 2019 Q2 | 4.5 Billion JPY | 31.58% |
| 2019 Q4 | 4.36 Billion JPY | -17.75% |
| 2019 FY | 17.59 Billion JPY | 11.45% |
| 2019 Q1 | 3.42 Billion JPY | -37.96% |
| 2019 Q3 | 5.3 Billion JPY | 17.91% |
| 2018 Q3 | 5.46 Billion JPY | 98.55% |
| 2018 Q4 | 5.51 Billion JPY | 0.86% |
| 2018 FY | 15.78 Billion JPY | -17.0% |
| 2018 Q1 | 2.05 Billion JPY | -74.07% |
| 2018 Q2 | 2.75 Billion JPY | 34.23% |
| 2017 Q4 | 7.9 Billion JPY | 40.01% |
| 2017 Q3 | 5.64 Billion JPY | 86.62% |
| 2017 Q2 | 3.02 Billion JPY | 24.52% |
| 2017 Q1 | 2.43 Billion JPY | -17.48% |
| 2017 FY | 19.01 Billion JPY | 33.5% |
| 2016 Q2 | 3.88 Billion JPY | 3.57% |
| 2016 Q3 | 3.65 Billion JPY | -5.89% |
| 2016 FY | 14.24 Billion JPY | -50.23% |
| 2016 Q4 | 2.94 Billion JPY | -19.46% |
| 2016 Q1 | 3.75 Billion JPY | -73.72% |
| 2015 FY | 28.61 Billion JPY | 185.69% |
| 2015 Q3 | 8.22 Billion JPY | 140.32% |
| 2015 Q4 | 14.28 Billion JPY | 73.62% |
| 2015 Q2 | 3.42 Billion JPY | 27.39% |
| 2015 Q1 | 2.68 Billion JPY | 26.92% |
| 2014 Q3 | 5.27 Billion JPY | 1926.3% |
| 2014 Q4 | 2.11 Billion JPY | -59.89% |
| 2014 FY | 10.01 Billion JPY | -18.75% |
| 2014 Q1 | 2.91 Billion JPY | 53.53% |
| 2014 Q2 | -289 Million JPY | -109.93% |
| 2013 Q2 | 2.86 Billion JPY | 17.4% |
| 2013 Q4 | 1.89 Billion JPY | -63.07% |
| 2013 FY | 12.32 Billion JPY | -22.35% |
| 2013 Q1 | 2.43 Billion JPY | -53.42% |
| 2013 Q3 | 5.13 Billion JPY | 79.45% |
| 2012 Q3 | 3.39 Billion JPY | -22.16% |
| 2012 FY | 15.87 Billion JPY | 12.82% |
| 2012 Q1 | 2.89 Billion JPY | -55.09% |
| 2012 Q2 | 4.35 Billion JPY | 50.67% |
| 2012 Q4 | 5.23 Billion JPY | 54.2% |
| 2011 Q4 | 6.44 Billion JPY | 82.96% |
| 2011 FY | 14.07 Billion JPY | 141.02% |
| 2011 Q1 | 1.74 Billion JPY | 361.47% |
| 2011 Q2 | 2.36 Billion JPY | 35.67% |
| 2011 Q3 | 3.52 Billion JPY | 48.82% |
| 2010 Q1 | 2.77 Billion JPY | -35.3% |
| 2010 Q4 | -667 Million JPY | -146.13% |
| 2010 FY | 5.83 Billion JPY | -46.62% |
| 2010 Q3 | 1.44 Billion JPY | -36.75% |
| 2010 Q2 | 2.28 Billion JPY | -17.56% |
| 2009 Q4 | 4.28 Billion JPY | 14.69% |
| 2009 Q1 | 1.29 Billion JPY | 147.18% |
| 2009 Q2 | 1.61 Billion JPY | 24.58% |
| 2009 FY | 10.93 Billion JPY | 262.1% |
| 2009 Q3 | 3.73 Billion JPY | 131.11% |
| 2008 Q2 | 2.04 Billion JPY | 0.0% |
| 2008 Q3 | 1.4 Billion JPY | -31.54% |
| 2008 Q4 | -2.75 Billion JPY | -296.22% |
| 2008 FY | 3.02 Billion JPY | -70.58% |
| 2007 FY | 10.26 Billion JPY | 10.01% |
| 2006 FY | 9.33 Billion JPY | 54.07% |
| 2005 FY | 6.05 Billion JPY | 78.31% |
| 2004 FY | 3.39 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | -278.075% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 90.97% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 105.458% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 88.726% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 9987.423% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 38.409% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | -103.206% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 63.805% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -2599.86% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | -46.814% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | -233.121% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -884.267% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 4013.158% |
| Tsumura & Co. | 20.01 Billion JPY | 3.432% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -381.23% |
| Torii Pharmaceutical Co., Ltd. | 5.03 Billion JPY | -283.856% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | -9.536% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -401.063% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | -98.947% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | -221.487% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 727.834% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -396.43% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 2481.639% |
| MedRx Co., Ltd | -933 Million JPY | 2171.919% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | -275.214% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 1797.191% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 915.654% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | -197.4% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | -2.356% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 2871.72% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -341.114% |